Comparison of commercial methods of immunoblot, ELISA, and chemiluminescent immunoassay for detecting type‐specific herpes simplex viruses‐1 and ‐2 IgG

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-2825|32|1|jcla.22203-jcla.22203

ISSN： 0887-8013

Source： Journal Of Clinical Laboratory Analysis (Electronic), Vol.32, Iss.1, 2018-01, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oncolytic Herpes Simplex Virus Type 1 and Host Immune Responses

By  

Current Cancer Drug Targets, Vol. 7, Iss. 2, 2007-03 ,pp. : 149-155

Bentham Science Publishers

Access to resources Recommend Favorite

Piroxicam inhibits herpes simplex virus type 1 infection in vitro

By  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 5, 2015-01 ,pp. : 331-336

Govi-Verlag

Access to resources Recommend Favorite

Herpes Simplex Viruses in Antiviral Drug Discovery

By  

Current Pharmaceutical Design, Vol. 12, Iss. 11, 2006-04 ,pp. : 1357-1370

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Oncolytic Herpes Simplex Viruses for Aggressive Cancers

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 9, 2012-07 ,pp. : 1786-1794

Bentham Science Publishers

Access to resources Recommend Favorite

QUANTITATIVE MODELING OF SUPPRESSION OF IgG1, IgG2a, IL-2, and IL-4 RESPONSES TO ANTIGEN IN MICE TREATED WITH EXOGENOUS CORTICOSTERONE OR RESTRAINT STRESS

By Pruett Stephen B.   Fan Ruping  

Journal of Toxicology and Environmental Health, Vol. 62, Iss. 3, 2001-02 ,pp. : 175-189

Taylor & Francis Ltd

Access to resources Recommend Favorite